Eli Lilly and Company India (Lilly), a leading innovation-driven corporation, and Boehringer Ingelheim India, the world’s 20 leading pharmaceutical companies, recently announced the launch of HumaPen SAVVIO, an innovative insulin delivery pen that meets the diabetics’ individual need. This latest innovation is engineered to resemble as a small personal accessory rather than a medical device.
HumaPen SAVVIO, an invention by Lilly, offers an extended shelf life of up to six years after first use. It was designed following feedback from people with diabetes who shared their aspiration to manage diabetes discreetly.
HumaPen SAVVIO, an original research product of Lilly will be co-promoted by the Lilly-Boehringer Ingelheim alliance in India.
Announcing the launch, Edgard Olaizola, managing director, Eli Lilly and Company India said, “The launch of HumaPen SAVVIO marks an important milestone for Lilly, reflecting our ongoing commitment to develop ‘people-led’ innovative solutions for diabetes. At Lilly, we recognize that people are unique and that their insulin delivery devices should reflect their lifestyle and personality. That’s why we developed HumaPen SAVVIO to be lightweight, portable and available in a choice of colours. It will help to bring a greater sense of normalcy to using insulin. We will continue to introduce innovative products to address the unmet needs of patients amidst the growing Indian diabetes epidemic.”
Commenting on the launch, Sharad Tyagi, managing director, Boehringer Ingelheim India said, “After the successful launch of Trajenta by the Lilly-Boehringer Ingelheim Alliance, this is another revolutionary product for the huge diabetes market in India. HumaPen Savvio is in line with alliance’s ongoing commitment to provide innovative solutions for diabetes treatment. We are constantly working towards pioneering interventions by leveraging scientific know-how and commercial capabilities of both companies and expanding our product portfolio for diabetes in India.”
The new HumaPen SAVVIO is short in size, lightweight, dependable, durable, easy to use insulin pen that will improve the everyday lives of people with diabetes. To boost the personal confidence of diabetics, the device is designed similar to a fashionable, compact pen with durable design and will be available in a range of colours – red, graphite, green and silver. HumaPen SAVVIO also makes dosing easy and insulin delivery discreet, which helps insulin users feel more at ease when using their medication.
HumaPen SAVVIO is supported by Lilly’s Diabetes Educators Service. Spread across the country, Diabetes Educators provide education/counselling on diabetes, nutrition, self-management, lifestyle management, hypoglycaemia and appropriate use of injectable devices under the guidance of treating physicians.
HumaPen SAVVIO will be available in India across six metros viz. Delhi, Mumbai, Kolkata, Chennai, Hyderabad and Bengaluru for use with 3 mL insulin cartridges Humalog, Humalog Mix25 and Humalog Mix50 on doctor’s prescription.